 |
|
Age Effects on Antidepressant-Induced Manic Conversion
Andrés Martin, MD, MPH;
Christopher Young, MD;
James F. Leckman, MD;
Chengeto Mukonoweshuro, DMD, MPH;
Robert Rosenheck, MD;
Douglas Leslie, PhD
Arch Pediatr Adolesc Med. 2004;158:773-780.
Background Antidepressant drug therapy can precipitate mania in vulnerable individuals, but little is known about the effects of age on this phenomenon.
Objective To pharmacoepidemiologically evaluate the risk of conversion to mania by antidepressant class and patient age.
Design, Setting, and Patients Using an administrative national database of more than 7 million privately insured individuals, linked outpatient and pharmacy claims were analyzed for mental health users aged 5 to 29 years (N = 87 920).
Main Outcome Measures The proportion and cumulative hazard of manic conversion were analyzed by antidepressant class and subject age among children, adolescents, and young adults with an anxiety or nonbipolar mood disorder in the United States between January 1, 1997, and December 31, 2001. Manic conversion was defined as a new diagnosis of bipolar illness.
Results During median follow-up of 41 weeks (range, 8-251 weeks), manic conversion occurred in 4786 patients (5.4%). Multivariate analyses using time-dependent Cox proportional hazards models indicated that an increased risk of manic conversion was associated with antidepressant category vs no antidepressant exposure (hazard ratios: 2.1 for selective serotonin reuptake inhibitors, P<.001; 3.8 for "other" antidepressants, P<.001; and 3.9 for tricyclic antidepressants, P = .002). Antidepressant x age interactions revealed inverse age effects for selective serotonin reuptake inhibitors and other antidepressants ( = –.05; P<.001 for both) but not for tricyclic antidepressants ( = –.02; P = .25). Peripubertal children exposed to antidepressants were at highest risk of conversion (number needed to harm: 10 [95% confidence interval, 9-12] among 10- to 14-year-olds vs 23 [95% confidence interval, 21-25] among 15- to 29-year-olds).
Conclusions Patient age is an effect modifier on the risk of antidepressant-associated manic conversion. Treatment with antidepressants is associated with highest conversion hazards among children aged 10 to 14 years.
From the Child Study Center (Drs Martin, Young, Leckman, and Rosenheck), the Department of Psychiatry (Drs Martin, Leckman, Rosenheck, and Leslie), and the School of Epidemiology and Public Health (Drs Mukonoweshuro, Rosenheck, and Leslie), Yale University School of Medicine, New Haven, Conn; Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Young); and the Northeast Program Evaluation Center, West Haven, Conn (Drs Rosenheck and Leslie).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Pediatrics 2009;123:1223-1228.
ABSTRACT
| FULL TEXT
Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force
Williams et al.
Pediatrics 2009;123:e716-e735.
ABSTRACT
| FULL TEXT
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders
Focus 2008;6:379-400.
ABSTRACT
| FULL TEXT
A Developmental Perspective on the Controversy Surrounding the Use of SSRIs to Treat Pediatric Depression
Leckman and King
Am. J. Psychiatry 2007;164:1304-1306.
FULL TEXT
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials
Bridge et al.
JAMA 2007;297:1683-1696.
ABSTRACT
| FULL TEXT
Defining the Boundaries of Childhood Bipolar Disorder
Ghaemi and Martin
Am. J. Psychiatry 2007;164:185-188.
FULL TEXT
The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide
Gibbons et al.
Am. J. Psychiatry 2006;163:1898-1904.
ABSTRACT
| FULL TEXT
US Suicide Rates by Age Group, 1970-2002: An Examination of Recent Trends
McKeown et al.
AJPH 2006;96:1744-1751.
ABSTRACT
| FULL TEXT
Should Selective Serotonin Reuptake Inhibitors Be Prescribed for Children With Major Depressive and Anxiety Disorders?
Safer
Pediatrics 2006;118:1248-1251.
FULL TEXT
Stimulating: Prescribing Amidst Controversy
Martin
Am. J. Psychiatry 2006;163:574-577.
FULL TEXT
Recognizing and treating depression in children and adolescents
Dopheide
Am J Health Syst Pharm 2006;63:233-243.
ABSTRACT
| FULL TEXT
Risk of Mania With Antidepressants
Baldessarini et al.
Arch Pediatr Adolesc Med 2005;159:298-298.
FULL TEXT
Risk of Mania With Antidepressants--Reply
Martin et al.
Arch Pediatr Adolesc Med 2005;159:298-299.
FULL TEXT
Antidepressants and Pediatric Depression -- The Risk of Doing Nothing
Brent
NEJM 2004;351:1598-1601.
FULL TEXT
The Rewards of Reducing Risk
Brent
Arch Pediatr Adolesc Med 2004;158:824-825.
FULL TEXT
|
